Skip to content

Study of the Prevalence of Diabetes and Pre-diabetes in Réunion Island

Study of the Prevalence of Diabetes and Pre-diabetes in Réunion Island

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06473584
Acronym
PREVADIABRUN
Enrollment
2000
Registered
2024-06-25
Start date
2025-04-02
Completion date
2026-12-31
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

In view of the new priority given to diabetes in Réunion and the implementation of an ambitious plan to combat the disease at regional level, which includes the identification and management of pre-diabetes, the need for up-to-date data on the extent of these 2 diseases (diabetes and pre-diabetes) has become essential. These two diseases have known risk factors: age, overweight, obesity, high waist circumference, family history, hypertension, eating habits and physical activity, all of which form part of a risk score for developing diabetes: the Findrisk recommended by the Haute Autorité de Santé for identifying people at risk of diabetes. Given the specific population characteristics of Réunion compared with Finland, where this score has been validated, it would seem important to be able to measure these risk indicators in the population as a function of carbohydrate status in order to check that the proposed thresholds are appropriate for the population of Réunion. Finally, cardiovascular risk has been described as early as the pre-diabetes stage. Given the young age of onset of diabetes in Réunion and the high proportion of diagnoses of diabetes made following the occurrence of a cardiovascular complication, the study of the prognosis of carbohydrate status on the occurrence of complications using the social security information system will be offered on a voluntary basis to study subjects (via a probabilistic social security link).

Interventions

DIAGNOSTIC_TESTDiabetes detection

Fasting glycemia on blood sample

Sponsors

Centre Hospitalier Universitaire de la Réunion
Lead SponsorOTHER
Agence Régionale de Santé de La Réunion
CollaboratorUNKNOWN

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Have lived in Réunion island for at least one year * Be aged between 18 and 75 * Affiliated to or benefiting from a social security scheme * Free, informed and signed consent

Exclusion criteria

* No main residence on the island or fixed address for at least one year on the island * Participation in experimental research * Pregnant women * Adults under guardianship or legal protection * Not understanding French

Design outcomes

Primary

MeasureTime frameDescription
Estimating the prevalence of glycaemic abnormalities (diabetes and pre-diabetes) in RéunionDay 1Measurement of fasting blood glucose and blood glucose 2 hours after ingesting 75g of glucose (HGPO test) according to Haute Autorite de Sante (HAS) recommendations used in France for diagnosing diabetes and pre-diabetes in people with unknown diabetes

Countries

Reunion

Contacts

CONTACTCatherine MARIMOUTOU, MD, PhD
catherine.marimoutou@chu-reunion.fr+262 (0)262 90 50 50
CONTACTFlorence LEFEBVRE D'HELLENCOURT
florence.lefebvre-dhellencourt@chu-reunion.fr+262 262 75 34 71
PRINCIPAL_INVESTIGATORCatherine MARIMOUTOU, MD, PhD

CHU La Réunion

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 15, 2026